BABE-2011 will serve as a catalyst for the advancement of Bioavailability & Bioequivalence studies by connecting scientists within and across disciplines at sessions and exhibitions held at the venue that create an environment conducive to information exchange, generation of new ideas, and acceleration of applications that benefit pharma and biotech industries.

The previous OMICS group conferences had played a leading role in facilitating researchers to discuss and analyze novel approaches of Bioavailability & Bioequivalence studies. BABE-2011 meeting will feature a scientific program of comprehensive talks, special sessions, oral and poster presentations of peer-reviewed contributions.